BLTE
Belite Bio Inc

228
Mkt Cap
$3.19B
Volume
79,095.00
52W High
$99.00
52W Low
$49.00
PE Ratio
-63.30
BLTE Fundamentals
Price
$98.10
Prev Close
$98.00
Open
$97.50
50D MA
$75.36
Beta
0.41
Avg. Volume
51,242.48
EPS (Annual)
-$1.18
P/B
21.34
Rev/Employee
$0.00
Loading...
Loading...
Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
25

Frequently Asked Questions

What is Market Cap of Belite Bio Inc - ADR?
What is the 52-week high for Belite Bio Inc - ADR?
What is the 52-week low for Belite Bio Inc - ADR?
What is Belite Bio Inc - ADR stock price today?
What was Belite Bio Inc - ADR stock price yesterday?
What is the PE ratio of Belite Bio Inc - ADR?
What is the Price-to-Book ratio of Belite Bio Inc - ADR?
What is the 50-day moving average of Belite Bio Inc - ADR?
How many employess does Belite Bio Inc - ADR has?

Latest BLTE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.